Abstract
Antibiotics continue to be our major therapeutic resource for curing and preventing infectious diseases. Their introduction in the 1940s totally revolutionized the treatment of human infections, and the successes of antibiotics continue to prompt their immediate use when an infectious bacterial cause is suspected. The myth of the so-called “miracle drugs” persists today, however, as people unthinkingly demand antibiotics for ailments for which these agents have no value. In turn, their effectiveness is often diminished, tarnishing their reputations and putting us at risk from unresponding infection by drug resistant forms of bacteria.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
References Cited
Cohen, D., Creek, G., and Sayers, R. Haemophilus influenzae infections in American children living in the U.K. Lancet i:101, 1982.
Bibliography Chapter 5
Broome, C. V., Mortimer, E. A., Katz, S. L. et al. Use of chemoprophylaxis to prevent the spread of Hemophilus influenzae b in day-care facilities. N. Engl. J. Med.316:1226–1228, 1987.
Classen, D. C., Evans, R. S., Pestotnik, S. L. et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N. Engl. J. Med.326:281–286, 1992.
Col, N. F. and O’Connor, R. W. Estimating worldwide current antibiotic usage: Report of Task Force 1. Rev. Infect. Dis. 9:S232–243, 1987.
Knapp, J. S., Zenilman, J. M., Biddle, J. W. et al. Distribution and frequency of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline (TRNG) in the United States. J. Infect. Dis.155:819–822, 1987.
Kunin, C. M., Lipton, H. L., Tupasi, T. et al. Social, behavioral and practical factors affecting antibiotic use worldwide: report of Task Force 4. Rev. Infect. Dis. 9: S270–285, 1987.
Morse, S. A. Antibiotic resistance in Neisseria gonorrhoeae: implications for future therapy. APUA Newsletter 8:4:1, 7–8, 1990.
Parker, C. W. Drug Allergy. N. Engl J. Med.292:732–736, 1975.
Reid, G. and Sobel, J. D. Bacterial adherence in the pathogenesis of urinary tract infection: a review. Rev. Infect. Dis.9:470–487, 1987.
Seppala, H., Nissinen, A., Jarvinen, H. et al. Resistance to erythromycin in Group A streptococci. N. Engl. J. Med.326:292–297, 1992.
Wald, E. R. Sinusitis in children. N. Engl. J. Med. 326:319–323, 1992.
Rights and permissions
Copyright information
© 1992 Stuart B. Levy
About this chapter
Cite this chapter
Levy, S.B. (1992). The Antibiotic Myth. In: The Antibiotic Paradox. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-6042-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-6042-9_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44331-2
Online ISBN: 978-1-4899-6042-9
eBook Packages: Springer Book Archive